InvestorsObserver
×
News Home

Is Rocket Pharmaceuticals Inc (RCKT) a Leader in the Healthcare Sector?

Tuesday, November 08, 2022 12:30 PM | InvestorsObserver Analysts

Mentioned in this article

Is Rocket Pharmaceuticals Inc (RCKT) a Leader in the Healthcare Sector?

The 71 rating InvestorsObserver gives to Rocket Pharmaceuticals Inc (RCKT) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 97 percent of stocks in the Healthcare sector, RCKT’s 71 overall rating means the stock scores better than 71 of all stocks.

Overall Score - 71
RCKT has an Overall Score of 71. Find out what this means to you and get the rest of the rankings on RCKT!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 71 would rank higher than 71 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Rocket Pharmaceuticals Inc Stock Today?

Rocket Pharmaceuticals Inc (RCKT) stock is trading at $16.91 as of 12:29 PM on Tuesday, Nov 8, an increase of $0.67, or 4.09% from the previous closing price of $16.24. The stock has traded between $16.61 and $17.30 so far today. Volume today is light. So far 304,315 shares have traded compared to average volume of 1,032,619 shares. Click Here to get the full Stock Report for Rocket Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App